NFE2L2 and neurodegenerative disease: In patients with mild cognitive impairment and other neurodegenerative diseases, the expression of Nrf2-ARE signaling pathway components also decreases, which causes mitochondrial dysfunction, oxidative stress, inflammation upregulation, and downregulation of antioxidases and neuroprotective effects, before leading to cognitive impairment [6].